Peripheral-Central Interplay for Fatiguing Unresisted Repetitive Movements: A Study Using Muscle Ischaemia and m1 Neuromodulation by Madinabeitia-Mancebo, Elena et al.
1
Vol.:(0123456789)
Scientific Reports |         (2021) 11:2075  | https://doi.org/10.1038/s41598-020-80743-x
www.nature.com/scientificreports
Peripheral‑central interplay 
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Maximal‑rate rhythmic repetitive movements cannot be sustained for very long, even if unresisted. 
Peripheral and central mechanisms of fatigue, such as the slowing of muscle relaxation and an 
increase in M1‑GABAb inhibition, act alongside the reduction of maximal execution rates. However, 
maximal muscle force appears unaffected, and it is unknown whether the increased excitability of M1 
GABAergic interneurons is an adaptation to the waning of muscle contractility in these movements. 
Here, we observed increased M1  GABAb inhibition at the end of 30 s of a maximal‑rate finger‑tapping 
(FT) task that caused fatigue and muscle slowdown in a sample of 19 healthy participants. The former 
recovered a few seconds after FT ended, regardless of whether muscle ischaemia was used to keep the 
muscle slowed down. Therefore, the increased excitability of M1‑GABAb circuits does not appear to 
be mediated by afferent feedback from the muscle. In the same subjects, continuous (inhibitory) and 
intermittent (excitatory) theta‑burst stimulation (TBS) was used to modulate M1 excitability and to 
understand the underlying central mechanisms within the motor cortex. The effect produced by TBS 
on M1 excitability did not affect FT performance. We conclude that fatigue during brief, maximal‑rate 
unresisted repetitive movements has supraspinal components, with origins upstream of the motor 
cortex.
Maximal-rate rhythmic repetitive movements (RRMs) cannot be sustained for very long, even when the move-
ments are unresisted, and it is known that the slowing of muscle relaxation is a major peripheral mechanism 
of RRM  fatigue1,2. However, there is also growing evidence for a neural origin of fatigue during these types of 
 movements3–5, and their characteristics clearly differ from those expressed during fatiguing isometric contrac-
tions performed with the same body segment and for an equivalent period of  time6,7.
During maximal-rate finger tapping (FT), even for periods as short as 30 s, the tapping frequency reduces 
rapidly, the muscle slows, and the excitability of spinal motor neurons and M1 inhibitory interneurons (operating 
through  GABAb receptors)  increases6–8. Movement deterioration during fatiguing FT is similar to that observed 
during unresisted RRM executed by other body  segments5. This observation suggests that fatigue may impact 
central structures engaged in rhythm formation and stresses the importance of understanding the physiological 
mechanism of fatigue in many situations, such as activities of daily living, sports, and the care of neurological 
patients. Likewise, because fatigue deteriorates different unresisted RRM in similar  manners5, the use of FT 
is supported as a model for the study of some components of fatigue in these movements. On the other hand, 
non-invasive brain stimulation techniques offer the possibility of modifying cortical excitability in an attempt to 
avoid fatigue development during these types of movements, but the protocol to be used (to increase or decrease 
excitability) would depend on whether the increased excitability of M1 inhibitory  interneurons6–8 is a central 
adaptation to waning muscle  contractility8.
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Central adaptations to the fatigued muscle state have been studied in different ways, one of which is to main-
tain muscle  ischaemia9–13. In the fatigued muscle, there is an increase in the concentrations of metabolites (such 
as  H+, ADP, or  Pi) and a decrease in ATP turnover, which may cause the contractile properties of the muscle 
to slow and may simultaneously stimulate different muscle nociceptors and chemoreceptors. These receptors 
(polymodal free nerve  endings14,15) give rise to small afferents (type III and IV) that project to different levels of 
the central nervous  system15–17, such as the inhibitory interneurons at the spinal  cord18. Contractility slowdown 
remains if blood flow is occluded using a  cuff19, which is thought to impair metabolic restoration in the muscle 
and keep the free nerve endings stimulated. Under these conditions, the contractile properties of the muscle do 
not recover until ischaemia is  relieved19.
To shed light on the fundamental mechanisms of fatigue, we test for peripheral-central interplay in the context 
of fatiguing unresisted repetitive movements. We employed the FT test, a well-known test for studying rhythmic-
ity control at the clinical  level20. In contrast to resisted repetitive actions such as  cycling21, unresisted repetitive 
movements require low levels of muscle force, and the effects of fatigue in these tasks do not compromise central 
drive to the muscle or muscle force generation, at least for short-duration  tasks8,22.
In this work, our aim was to test whether the increased  GABAb inhibition in  M16–8 and the impairment in 
muscle  contractility8 observed during maximal-rate unresisted RRM were related. Therefore, we recorded M1 
GABA inhibition by means of transcranial magnetic stimulation-induced silent periods (TMS-SPs)23 during 
maximal voluntary contraction (MVC) and muscle contractility slowdown by means of the half-relaxation time 
(HRT)1,2,8 immediately after a fatiguing FT task (without resting time). However, in some sets, the SP and HRT 
were recorded after a period of 10 s of rest from FT, which is sufficient time to allow complete SP  recovery24. To 
ensure that the contractile properties of the muscle remained slow at the time of recording (i.e., 10 s after FT), 
we tested these variables while imposing muscle ischaemia in some of the  sets10,12,25,26 (Fig. 1 briefly summarizes 
the protocol, further detailed in the “Methods”).
As per our hypothesis, if SP recovers within 10 s of stopping FT as the muscle is slowing down, the increase 
in SP observed at the very end of  FT6–8 would not be representative of a central adaptation to the muscle state. 
Conversely, if SP remains enlarged after 10 s from the end of FT during muscle ischaemia, the increase in the 
excitability of M1-GABA interneurons (in this case, inhibition mediated by  GABAb receptors) would likely be 
due to a supraspinal adaptation to a less functional muscle.
Once such central-peripheral interplay is defined, the modulation of M1 excitability might clarify some of 
the mechanisms involved in this interaction. It might also contribute to reduced fatigue during the task. For 
these reasons, the protocol outlined above was performed in combination with neuromodulation techniques in 
a randomized order in three different sessions: continuous and intermittent theta-burst transcranial magnetic 
stimulation of M1 (cTBS and iTBS, respectively) and shamTBS. cTBS and iTBS are neuromodulation techniques 
generally accepted to decrease and increase excitability,  respectively27,28.
As per our second hypothesis, if the shamTBS session shows that the increased  GABAb inhibition in M1 
is a central adaptation to a less functional muscle, increasing M1 excitability with TBS will not reduce fatigue 
development. In fact, it might have detrimental effects. In such a case, decreasing M1 excitability might produce 
superior FT performance.
Results
Table 1 shows the normalizing scores of the outcome variables in the 3 sessions (n = 19 completed all sessions). 
These scores did not differ significantly across sessions and correspond to the units of the y-axes in the graphs.
Effect of slowing muscle relaxation on increased M1‑GABAb inhibition after fatiguing FT. To 
test our first hypothesis, we analysed the shamTBS session. The maximal rate of FT decreased in 30 s  (F1,18 = 153.4, 
p < 0.001TIME) and the PRE-POST decrement was ≈ 15%. However, from set to set, the FT rate increased 
 (F2,36 = 13.0ε=0.6, p < 0.001SET); the change was small (≈ 4%) and likely reflected learning effects (Fig. 2A).
The range of motion amplitude during FT also increased at the end of the task  (F1,18 = 15.1, p = 0.001TIME, 
Fig. 2B). The change in magnitude was small (≈ 5%) and was present in all sets. The remaining main effects and 
interactions were not significant.
At the peripheral level, muscle contractility slowed POST FT  (F1,18 = 12.6, p = 0.002TIME); this is expressed by 
an ≈ 7% increase in HRT in all sets (the remaining factors and interactions were not significant). The absence 
of significant interactions of the TIME factor (PRE-POST) with other factors implied that the muscle slowing 
observed at POST-T0 remained at T10 for all conditions (Fig. 2C). Importantly, the change in HRT was not 
influenced by changes in muscle temperature, as temperature was experimentally controlled and constant for 
the duration of the session [33.4 °C, standard error of the mean (SE) 1.3] (main effects and interactions were 
not significant).
M1-GABAb inhibition (i.e., FDI SP duration) changed at the very end of FT  (F1,18 = 47.7, p < 0.001TIME), but 
did so differently for the two delays tested  (F1,18 = 104.8, p < 0.001TIME X DELAY). Post hoc analyses showed that SP 
tested immediately after FT (T0) increased from PRE to POST by ≈ 12% (p < 0.001), but not if tested after 10 s of 
rest (POST-T10), where it was 2.5% smaller than PRE (p = 0.002) (Fig. 2D). In all conditions and for set progres-
sion, the SP duration increased slightly but significantly (≈ 3.5% from the beginning to the end of the protocol, 
 F2,36 = 10.1, p < 0.001SET; effect omitted in graphs). Figure 2E shows individual recordings of FDI SP and HRT on 
a PRE-POST basis for the different conditions.
In summary, increased  GABAb-mediated inhibition in M1 was evident immediately after FT, but SP recovered 
after 10 s of rest when the muscle remained slowed. Therefore, the increased SP duration observed right at the 
end of maximal-rate FT was not a response to reduced muscle contractility (i.e., increased HRT) observed at 
the end of the task.
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Figure 1.  Protocols used for FT fatigue testing. (A) Evaluation timeline and structure of FT fatigue testing 
conditions: after soaking the hand and forearm in a warm-water bath for 20 min, we determined the intensity 
of percutaneous electrical stimulation needed to acquire muscle resting twitches. Then, using paired-pulse 
TMS over M1, we tested corticospinal excitability with motor evoked potential (MEP) amplitudes and long 
intracortical inhibition (LICI). Next, we applied M1 theta-burst stimulation (TBS; intermittent [iTBS], 
continuous [cTBS] and sham [shamTBS] across different sessions, on different days), and MEP and LICI 
were retested. Each day, after receiving TBS, subjects performed two brief MVCs (with 3 min rest between) to 
determine the M1-TMS intensity to be used in the fatigue protocol; this was the intensity needed to produce 
SP durations of ≈ 200 ms in the two MVCs. Subsequently, subjects performed 12 FT sets (four different set-
conditions sequentially repeated three times) with 3 min rest between every set. The T0 NO-ISCHAEMIA 
condition started with a brief MVC (PRE) in response to a light-emitting diode (LED) turning on. At the MVC 
plateau, muscle force was recorded, and TMS was delivered to acquire SP; 500 ms after the TMS pulse, the LED 
turned off as a cue to stop the MVC. Three seconds later, and with the muscle at rest, we applied percutaneous 
nerve stimulation (a triplet at supramaximal intensity) to produce a resting muscle twitch. With this twitch, we 
calculated the HRT of the muscle offline. Next, 40 s after the sequence of events had started, subjects executed 
FT at the maximal possible rate for 30 s. Immediately after FT (with no gap), subjects performed another 
brief MVC (POST), and stimulations were applied as before. The remaining conditions were similar to those 
described above, with small differences. For T10 NO-ISCHAEMIA, the MVC POST FT (and stimulation) started 
after a delay of 10 s following the end of FT; during the delay, subjects remained at rest. For the ischaemia 
conditions (T0 ISCHAEMIA and T10 ISCHAEMIA), the sets were as above but had 20 s of muscle ischaemia at 
the time of stimulation testing. (B) Instrumentation and set-up: the different units are indicated by arrows in the 
panel. The apparatus was worn by the subjects immediately after removing their arms from the water bath. (C) 
Signal processing: this method was used to determine the features of the tapping profile, as described in detail in 
the “Methods” section.
Table 1.  Normalizing scores (mean across participants and standard error of the mean [SE]) for different 
sessions. Please see “Methods” for description. FT finger tapping, ROM range of motion amplitude, FDI SP first 
dorsal interosseous silent period, HRT half-relaxation time, MVC maximal voluntary contraction, SE standard 
error of the mean.
Maximal FT rate (Hertz, Hz)
Maximal possible active index 
finger ROM (°)
FDI SP duration at PRE 
(milliseconds, ms)
HRT
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Effect of real TBS on fatigue expressions. Figure 3A shows individual changes in cortical excitability 
produced by cTBS and iTBS compared to shamTBS, tested immediately before FT execution. We used these 
scores as covariates (CoVcTBS and CoViTBS) to evaluate the individuals’ aftereffects of TBS on fatigue profiles.
For the tapping rate, TBS produced no changes in subject performance (Fig. 3B). When we analysed responses 
after cTBS and compared them with those obtained after shamTBS, the factor STIM (including sham vs. cTBS 
levels) did not interact significantly with any other factors at the sample level or with the covariate CoVcTBS (at 
the individual level). The same applies for the analyses of sham and iTBS levels of factor STIM, with CoViTBS 
as a covariable. Likewise, the maximal tapping rates acquired along any of the testing points and sets did not 
differ across the sessions (Table 1).
Therefore, the changes in M1 excitability produced by TBS did not change either the maximal FT rate obtained 
at any of the protocol testing points (Table 1) or fatigue development during the 30 s.
The tapping ROM amplitude (Fig. 3C), HRT and FDI SP (Fig. 4A,B) followed similar patterns in their 
responses to TBS protocols. None of the variables changed significantly with cTBS or iTBS compared to shamTBS 
protocols at the group level or individually (when considering CoVcTBS and CoViTBS covariates).
Our set-up and experimental design was aimed to study the main FT flexor (i.e., TMS hotspot corresponded 
to first dorsal interosseous cortical representation, and HRT was tested during flexion force). As additional data, 
we also recorded electromyography activity from the extensor indicis muscle (EXT-IND). The responses of the 
EXT-IND SP followed the same pattern than FDI SP in the three sessions (Fig. 5).
In summary, the changes in M1 excitability produced by TBS did not change the tapping profiles during the 
fatiguing FT task.
Aftereffects of TBS on MVC muscle force. Although our primary objective was not to study TBS after-
effects on muscle force, we performed MVCs before and after FT to allow the recording of M1 SPs, and muscle 
force was analysed. In the shamTBS session, muscle force decreased from PRE to POST FT and progressively 











































































































































































































































































































































































































Figure 2.  Expression of fatigue in the absence of M1 neuromodulation (shamTBS session). (A) FT rate and (B) 
FT ROM amplitude variables are shown by pooling delays and ischaemia since these factors had no significant 
effects. The maximal FT rate decreased significantly in 30 s (PRE vs. POST) for all sets and conditions (both 
delay and ischaemia); with set progression, the maximal rate increased both at PRE and POST (p < 0.001, 
asterisk omitted). The FT ROM amplitude at POST was larger than PRE for all sets and conditions. (C) HRT 
and (D) FDI SP are split by delays and ischaemia conditions for visual comparison (solid bars = no ischaemia; 
textured bars = ischaemia); HRT showed similar changes for all of them. The HRT (C) increased significantly 
from PRE to POST, and this increase was not different across the delays (T0 and T10), ischaemia levels and 
set progression. The FDI SP (D) increase from PRE to POST was significant only for T0. For T10, SP was 
significantly reduced at POST. The effects of FT on SP were not different for the two ischaemia conditions. 
(E) Representative recordings of FDI SP and relaxation phase of the resting twitch from the same individual 



































































































































































































































































shamTBS session cTBS session iTBS session
Figure 3.  Effects of M1-TBS on fatigue expressions for maximal FT rate and FT ROM. (A) Individual responses 
to TBS; (A1) shows the individual scores of the ratio calculated with MEP amplitude PRE and POST TBS for 
each session  (SHAMRATIO,  cTBSRATIO and  iTBSRATIO). MEP amplitude scores (mean across participants) at PRE 
did not differ between sessions (ANOVA p = 0.33; 1.8 mV SE 0.3, 1.8 mV SE 0.3, 1.4 mV SE 0.2, respectively). 
(A2) shows the individual scores of the grand ratios  (cTBSRATIO/SHAMRATIO and  iTBSRATIO/SHAMRATIO). 
These scores indicate each individual response to cTBS and iTBS compared to shamTBS and were introduced 
in ANOVA as covariables to test the aftereffects of TBS on fatigue responses. (B) Maximal FT rate and (C) 
FT ROM amplitude at PRE and POST after different TBS protocols; cTBS and iTBS did not produce different 
responses compared to shamTBS for any variable, and this effect was not different for individual responses to 
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shamTBS session cTBS session iTBS session
Figure 4.  Effects of M1-TBS on HRT and FDI SP duration. (A) HRT and (B) FDI SP show results by pooling 
those from the ischaemia condition since ischaemia as a main effect was not significant and did not have any 
significant interactions with other factors. For both variables, the responses of cTBS and iTBS did not differ 
significantly from those observed for shamTBS. HRT increased significantly at POST (both T0 and T10). SP 
was significantly increased POST FT only for T0 and reduced at T10, and this did not differ across different 
TBS sessions. The insets indicate responses for HRT and SP before and after FT in the delay and ischaemia 
conditions for the three TBS protocols (solid bars = no ischaemia, textured bars = ischaemia); asterisks denoting 
significance were omitted as the effects were not different from the pooled responses in (A) and (B). **p ≤ 0.01, 
***p ≤ 0.001. The y-axis unit score values are shown in Table 1.
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force across sets was more pronounced before FT (at PRE) than at POST  (F2,36 = 12.4, p < 0.001TIME X SET) (Fig. 6 
inset). This response in the sham session was not different from the response observed in the cTBS session (i.e., 
the factor STIM [cTBS vs. shamTBS] and covariate CoVcTBS did not interact significantly with any other factor).
Conversely, this was not the case for iTBS, where the MVC force drop from PRE to POST FT differed from 
that observed for shamTBS  (F1,17 = 11.7, p = 0.003STIM×TIME). The effect was detected at the population level and 
was not dependent on the manner in which iTBS changed M1 excitability in individuals, as CoViTBS had no 
significant interactions.
Whereas the PRE-POST force loss was 5.7% for shamTBS (and 4.6% for cTBS), it was reduced by only 3.5% 
for the iTBS session (Fig. 6).
In summary, and in response to our second hypothesis, the aftereffects of TBS did not change the profile of 
fatigue during FT. This was observed in both the whole sample of participants and considering individual changes 
in corticospinal excitability after cTBS and iTBS. We also performed analyses considering TBS aftereffects on long 
intracortical inhibition (LICI; see “Methods”), but the results did not show any change from those reported above.
Discussion
Fatigue produced by unresisted RRM at the maximal rate has central and peripheral manifestations. When the 
maximal rate of FT drops at the end of 30 s, the contractility of the muscle  slows8 and M1 SP, not the spinal SP, 
 enlarges6–8. However, the central drive to the muscle remains  unchanged8.
In response to the first hypothesis proposed in this study, we determined that the increased inhibitory activity 
 (GABAb) at the level of M1 is not a response to waning muscle contractility. Therefore, the increased cortical SP 
observed at the end of fatiguing FT has a central origin.
The expressions of tapping fatigue observed in this study are consistent with previous works with similar 
 tasks6–8, showing null effects of our shamTBS protocol on behaviour. The maximal FT rate drop was ≈ 15% after 
30 s of  tapping6–8, the HRT increased by ≈ 7%8, and M1 silent periods enlarged by 12%6,8. However, 10 s of rest 
after FT allowed the SP to recover, even when the muscle remained slowed down.
Aside from the above results, there are three other observations from our study that deserve some commen-


















































































































































































Figure 5.  Effects of M1-TBS on extensor indicis SP duration. Ischaemia levels were pooled for extensor indicis 
(EXT-IND) SP, since they were not significantly different and had no significant interactions with other factors. 
Responses to cTBS and iTBS did not differ significantly from those observed after shamTBS. EXT-IND SP was 
significantly larger POST (vs. PRE) FT only for T0 but smaller for T10, and this did not differ across different 
TBS sessions. Figure insets indicate responses of EXT-IND SP before and after FT in delay and ischaemia 
conditions for the three TBS protocols (solid bars = no ischaemia, textured bars = ischaemia). The asterisks 
denoting significance were omitted because they were not significantly different from the pooled response in 
the main plot. **p ≤ 0.01, ***p ≤ 0.001. The y-axis unit scores are equivalent to PRE SP durations for the different 
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that these peripheral mechanisms of fatigue recover much more  slowly19 than central  expressions24. Second, 
when 10 s of rest was allowed after FT, the SP duration was smaller than PRE; thus, it not only recovered to 
baseline levels but also reduced even further. Despite the small magnitude of change (2.5%), this phenomenon 
suggests an active mechanism of recovery, either by disinhibition or by modification of excitation. Third, the first 
dorsal interosseous SP pattern of response was also observed for SP recorded from the extensor indicis muscle. 
Although our set-up and design aimed at testing the main FT flexor (i.e., TMS hotspot was on first dorsal interos-
seous cortical representation, and HRT was tested on flexion force), we also recorded electromyography (EMG) 
activity from the extensor indicis, whose SP duration behaved the same as that of the first dorsal interosseous. 
This observation (similar response in antagonistic muscles) reinforces the concept that increased M1  GABAb 
inhibition originates at central levels and not from afferent feedback; the latter is mainly homologous but can 
also affect antagonist  muscles29 (or even act trans-segmentally30). It is worth mentioning that an antagonistic 
mechanism of inhibition is absent in our work because both the first dorsal interosseous and extensor indicis SPs 
recovered in the presence of muscle slowdown.
On the other hand, the results of maximal voluntary force indicated that it dropped at the very end of FT 
and with set progression (in agreement with previous works that did not use neuromodulation  techniques6,7). 
However, we previously showed that the decline in force was not produced by  FT6–8 but was due to the repeated 
execution of MVC during the session (slow fatigue development did not affect cortical  SP6–8).
We observed a small but significant increase in SP duration from set to set, a profile very different from the 
large increase in SP seen at the end of fatiguing FT. Because SP recovery to pre-fatigue values is very rapid (less 
than 10  s24) and increased intracortical inhibition is also associated with motor learning, we believe that the small 
increase in SP duration observed from set to set in our study is produced by motor learning. In line with this 
possibility, maximal tapping frequency also increased across sets (another sign of learning). Learning in fast rate 
tapping has been previously described within  sessions31, and this fast learning modulates M1  excitability31,32. It is 
known that different inhibitory processes contribute to TMS-SP duration  (GABAa for short SPs and  GABAb for 
long SPs)23,33; for this reason, we propose that in our study, the effects of two different GABAergic networks can 
be identified: one is responsible for fatigue within sets after 30 s FT, and the other is related to learning across sets.
In summary, our results during the sham TBS session suggest that fatigue generation during unresisted RRM 
originates from two unrelated central and peripheral mechanisms. The increased  GABAb inhibition of M1 is 
not a response to the increased muscle relaxation slowdown observed at the end of FT. Provided that fatigue 
characteristics of rate drop for unresisted RRM are similar for very different effectors (such as finger and foot)5, 















































































































































shamTBS session cTBS session iTBS session
Figure 6.  Effects of M1-TBS on MVC force. MVC change (PRE vs. POST FT) by pooling sets (A) and with set 
progression (inset); (A) shows the results on a PRE-POST basis by pooling sets; the drop in MVC force POST 
FT was significantly smaller in the iTBS session than in the shamTBS session, but PRE-POST changes remained 
significant for all stimulation modes, as denoted by asterisks. In the three sessions conducted, MVC force 
decreased significantly with set progression, but the reduction was larger at PRE than at POST. The inset depicts 
the significantly different PRE-POST change with set progression and the significant change with set (asterisk 
omitted for clarity). ***p ≤ 0.001. The y-axis unit score values are shown in Table 1.
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Effects of changing M1 excitability with TBS on fatigue induced by maximal‑rate FT. Once a 
supraspinal origin of fatigue is defined, the aftereffects of TBS on M1 excitability would allow a more detailed 
understanding of its regulatory mechanisms. cTBS produced no effect on the tested variables, and behaviour 
during this session did not differ from that observed in the sham TBS session. This was not the case for the iTBS 
session; however, the iTBS impact did not focus on FT behaviour but on the force levels developed immediately 
after it.
iTBS modulates M1 excitability by acting on interneuronal populations engaged in the generation of 
late I-waves, recorded from the descending volleys towards spinal motor neurons, in response to corti-
cal  stimulation34. It is known that these late I-waves are dependent, at least in part, on  GABAb intracortical 
 inhibition23,35, which enlarges upon FT  fatigue6–8. Therefore, we might expect a clear aftereffect of iTBS upon 
FT fatigue, assuming that supraspinal fatigue originates at M1. However, we did not observe any changes upon 
FT fatigue in the whole sample of participants, even accounting for individual responses in M1 excitability to 
iTBS. These results support the idea that SP extension with fatigue originates at supraspinal structures other than 
M1, which might direct or indirectly target the motor cortex. This possibility is also supported by the fact that 
the aftereffects of the other active TBS protocol in our study, cTBS, did not change the FT profiles either. The 
supraspinal origin of fatigue outside M1 also appears to be a possibility for tasks different to unresisted RRM, 
for instance for sustained or repeated isometric  contractions36,37.
Previous studies applied neuromodulation techniques on repetitive movements but focussed on resisted con-
tractions such as cycling (see Machado et al.38 for review). In such studies, techniques such as anodal transcranial 
direct current stimulation and iTBS on M1 allowed either greater motor output generation or longer time to task 
 failure21,39,40. iTBS on M1 might be suitable for treating changes in force during fatigue; in fact, we also observed 
a positive aftereffect of iTBS in preventing loss of force. However, neither waning of muscle  force4,8,22 nor central 
drive to the  muscle8 are characteristic mechanisms of fatigue resulting from unresisted rhythmic movements, due 
to which iTBS might not be an effective solution for unresisted RRM fatigue. Alternatively, a central disruption in 
rhythmicity control might be the underlying cause (or an associated mechanism) of such a form of neural fatigue, 
as previously published results point to an increased co-activation of antagonistic  muscles5,22 and a breakdown 
of M1 surround  inhibition5 in such scenarios. Our observations of maximal tapping rate loss and the slight but 
significant increase in ROM amplitude might be the consequences of ineffective activation sequencing of index 
flexors and extensors (i.e., fast changes from extension to flexion). This implies that the central origins of fatigue 
emerge from a supraspinal network other than M1 deeply engaged in rhythmic formation (basal ganglia, for 
instance), even when the primary motor cortex might be one of the final nodes. Finally, a previous work indi-
cated that an excitatory protocol (paired-TMS at I-wave interval) combined with motor practice reduced the 
drop in tapping rate along 10 s of fast FT; however, in this case, tapping was not  maximal31, as clearly shown in 
a complementary experiment presented in Supplementary Fig. 1.
Conclusions
Unresisted repetitive movements at the maximal possible rate produce fatigue, expressed as a fast drop in the 
maximal movement rate and increased excitability of inhibitory  GABAb-dependent M1 intracortical circuits. 
This process is not mediated by afferent feedback from the muscle, but it originates at supraspinal levels.
The absence of any aftereffects of TBS (either cTBS or iTBS) on M1 for such behavioural and neurophysiologi-
cal landmarks suggests that the increased M1 inhibition with FT fatigue development is generated by supraspinal 
inputs targeting M1, perhaps arising from subcortical structures that are engaged in rhythm formation.
Methods
The protocols were bound by the Declaration of Helsinki and approved by the University of A Coruña Ethics 
Committee. Participants signed informed consent forms.
Participants. Nineteen of 23 healthy right-handed volunteers completed three scheduled sessions (10 males 
and 9 females; mean age 23.9 SEM 1.4); the 4 who refused to participate after the first session reported discom-
fort produced by the electric stimulation used in the protocol as cause of withdrawal. Sessions were identical in 
all respects, except for the kind of cortical stimulation applied prior to task execution. Cortical stimulation, as 
described below, included three types of TBS to modulate M1 excitability (shamTBS, cTBS and iTBS). The order 
of sessions was randomized across participants, with a minimum inter-session delay of 10 days.
Fatiguing FT testing protocol. Behavioural evaluation during the FT task was similar to a previously 
described  protocol8 (Fig. 1A). The upper dominant limb of the subjects was adapted to a 3D  system8, which 
secured the forearm and hand (with the thumb fixed in abduction) but left the index finger free to move around 
the metacarpophalangeal joint. A force load metre (P200 Biometrics Ltd.) was attached to the system under-
neath the tip of the index finger, and an electrogoniometer (S100 Biometrics Ltd.) monitored the range of motion 
of the index metacarpophalangeal joint (Fig. 1B).
A single session comprised 12 FT execution sets, with 3 min of rest in between sets. Every set included the 
following sequence of events:
• The set started with the execution of an MVC of the index finger against the force load metre in response 
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• During the MVC, a single TMS pulse was applied on the left M1, and the SP was recorded from the EMG 
activity. We monitored EMG activity from the superficial head of the first dorsal interosseous muscle, which 
is the main index metacarpophalangeal joint flexor when the thumb is fixed in abduction (other muscles 
were also monitored, some of them were for objectives unrelated to this study). The TMS pulse to induce SP 
was delivered at the time of the MVC peak by using a previously described and validated  algorithm8; 500 ms 
after the TMS pulse delivery, the LED turned off, prompting subjects to stop the MVC and relax.
• With the muscle at rest, 3 s after the LED turned off, we applied percutaneous electric stimulation of the 
ulnar nerve (a 100 Hz triplet) to produce a resting muscle twitch, whose force was recorded. This sequence 
of events comprised PRE testing before FT (Fig. 1A).
• Forty seconds after the LED turned on (≈ 38 s of rest after the end of MVC), a low tone auditory cue was 
used as a signal to start FT at the fastest possible rate for 30 s. The instructions given to the subjects were as 
follows: “Tap with your index finger on the force sensor at your maximal possible rate at all times from the 
very beginning of the task, indicated by an auditory cue, to the end of the task indicated by a second cue; 
always tap as fast as possible”. No instructions were given about FT ROM amplitude or tapping force on the 
plate.
• After tapping for 30 s, we performed testing and stimulation as previously described for PRE. However, this 
POST testing was performed at two different times: (i) immediately after finger tapping, without a time gap 
from FT to  MVC8 (T0), and (ii) after a 10 s period of rest (T10) from FT to MVC (Fig. 1A). Thus, for T0, 
subjects changed from FT to MVC without any time lag in response to the illumination of the LED. For T10, 
a non-startle auditory cue at the end of the 30 s of FT prompted subjects to stop tapping and rest for 10 s 
before performing the MVC.
Half of the 12 sets were T0, and the other half were T10, presented in a counterbalanced order. Subjects had no 
problems in understanding the instructions provided at the start of the protocol to execute the T0 and T10 sets. 
They were informed of the nature of the upcoming set (T0 or T10) during the 3 min rest periods, immediately 
prior to the start of the set. There were no mistakes during execution.
Ischaemia. During half of the T0 and T10 sets, PRE and POST testing were performed under ischaemic 
muscle conditions (Fig. 1A). Muscle ischaemia was produced by inflating a cuff (at 300 mmHg) placed around 
the arm immediately above the right elbow (Fig. 1B). The cuff was automatically inflated using an electric pump 
(at PRE, inflation started 4  s before the LED cue for MVC execution). Inflation at 300 mmHg was acquired 
in < 0.6 s and sustained for 20 s; it finished 24 s before the start of FT.
At POST, ischaemia started in all sets (either T0 or T10) at the 26th second of the 30 s FT task duration and 
was sustained for 20 s. Therefore, for the POST-10 testing, ischaemia ended ≈ 2 s after recording the resting 
muscle twitch induced by percutaneous nerve stimulation (see below).
In summary, in each set, we studied one of these four conditions:  T0NO-ISCHAEMIA,  T0ISCHAEMIA,  T10NO-ISCHAEMIA 
and  T10ISCHAEMIA. The presentation order of these four conditions in the first four sets was counterbalanced across 
participants, and this order was repeated for each subject in sets number 5–8 and 9–12. For a given subject, the 
sequence was repeated in the same order for all sessions (shamTBS, cTBS, or iTBS).
TMS. TMS was performed in different ways to test and modulate M1 excitability during each session. We 
used single and paired pulses and TBS, following this sequence (Fig. 1A):
 i. Evaluation of M1 excitability at rest using paired-pulse protocols (detailed below).
 ii. M1 excitability modulation with TBS, as described below.
 iii. M1 excitability was retested at rest with paired-pulse protocols (i. and iii. were meant to determine indi-
viduals’ response to TBS prior to FT execution).
 iv. M1 excitability was tested during the FT fatiguing protocol using single pulse TMS.
M1‑excitability evaluation protocol. In all the above cases, M1 excitability was tested with a MagPro 
X100 with the MagOption system connected to a figure-eight coil (MC-B70) placed over the hot-spot of the FDI 
muscle, which was determined before the theta-burst and fatiguing protocols. The coil position was marked on 
the scalp with a soft pen for monitoring position during the session.
For testing M1 excitability, TMS pulses were monophasic-waveform and the coil oriented to induce currents 
in M1 in a postero-anterior (PA) direction.
• Protocol for testing M1 excitability before the FT fatiguing protocol At rest, we tested corticospinal excitability 
and LICI (GABAb activity); this was the PRE value. Excitability was checked again in the same way after M1 
was modulated with TBS (POST; see description below, and Fig. 1A). This evaluation was meant to determine 
the individual response of each subject to TBS given the variable responses to this form of stimulation from 
subject to  subject41. We delivered 20 TMS paired pulses at PRE TBS (each pulse in the pair had the same 
intensity). TMS intensity was set to produce a Test-MEP (i.e., the first MEP of the pair) with an approximate 
amplitude of 1–1.5 mV; this first MEP amplitude was used to evaluate corticospinal excitability. The inter-
stimulus interval (ISI) between pulses was explored between 100 and 200 ms and was selected to obtain a 
conditioned MEP (i.e., second MEP) of ≈ 50% of the Test-MEP, mean ISI interval across participants was 
160.5 ms SE 4.9, range [130–200 ms]. The ISI determined in the first session was repeated in the other two ses-
sions. The ratio (2nd MEP/1st MEP amplitude) was used to obtain M1 LICI (which is  GABAb  dependent23).
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  Likewise, another 20 TMS pairs were delivered POST theta burst, with the same intensity as PRE.
• Testing M1 GABAb activity during the main FT fatigue protocol, the silent period Single pulses of TMS were 
delivered during MVCs (PRE and POST FT) at the moment the MVC peaked and force plateau started. The 
timing was controlled using a previously described and validated algorithm by computing the slope of the 
force exerted on the  dynamometer8. A video and data showing how the algorithm functions are  available8. 
TMS intensity was set to induce an SP duration of ≈ 200 ms in the fresh  muscle6,8, and the intensity was kept 
constant during the rest of the session.
Modulation of M1 excitability. We applied TBS to modulate M1 excitability just before FT (Fig. 1A), 
with the subjects at rest. We used the MagPro X100 system with a refrigerated figure-eight coil (Cool-B65) posi-
tioned over the hotspot of the FDI muscle (the position was recalculated as this coil size was different). Biphasic 
waveform pulses were delivered to induce currents in the brain in a postero-anterior/antero-posterior direction. 
Stimulation intensity was set at 80% of the active motor threshold determined, immediately before TBS, with 
the Cool-B65 coil and biphasic waveform on the first dorsal interosseous hotspot for each session. A total of 600 
pulses were delivered according to the iTBS and cTBS protocols described by Huang et al.42. For the shamTBS 
session, an unplugged figure-eight coil was placed over the first dorsal interosseous hotspot with another (fully 
operative) coil tilted at an angle of 90° over the first  coil43,44.
Electric percutaneous nerve stimulation. To test contractile muscle properties during the FT fatiguing 
protocol, we applied percutaneous nerve stimulation on the ulnar nerve at the elbow with a Digitimer DS7AH 
electric stimulator (0.2 ms pulse width). The anode was placed lateral to the medial epicondyle of the humerus 
along the post-condylar groove; the cathode was ≈ 2 cm distal to the anode on the nerve. Stimulation was a 
100 Hz triplet at supramaximal intensity, which was 150% of the intensity needed to obtain maximal compound 
muscle action potential in the first dorsal interosseous  muscle8. This intensity was calculated at the beginning of 
each session before any action was performed by the subjects (Fig. 1A). The force of the muscle twitch produced 
by the triplet was recorded by the dynamometer and used offline to calculate the half relaxation time. The half 
relaxation time reflects the contractile properties of the muscle and is defined as the time period from peak force 
to 50% of the peak force, calculated during the relaxation phase of the muscle twitch induced by the triplet. Since 
half relaxation time depends on muscle  temperature19,45, we monitored and controlled muscle temperature for 
all the experimental sessions.
Muscle temperature monitoring and stabilization. At the beginning of every experimental session, 
the participant’s dominant hand and forearm were immersed in a bath of warm water (≈ 33 °C) for 20  min45. 
During the fatiguing protocol, a thin temperature probe (3 mm tip YSI Temperature Probe, YSI Inc., Dayton, 
OH, US) was placed just beneath the adhesive part of the surface EMG electrode on the FDI muscle. The probe 
connected to an amplifier (CITER, CIBERTEC Ltd.) that sampled temperature (at 0.1 Hz) and sent the reading 
to a control unit (CED1401mkII, unit-1). Temperature was maintained at a stable level for the entire duration 
of the FT protocol by means of a flow of cool or warm air, as needed (Fig. 1B shows one of the fans used, placed 
aside for visibility of other components). Muscle temperature was estimated based on previous  studies45: muscle 
temperature = 1.02 skin temperature + 0.89.
Variable acquisition. MEPs, EMG activity and SP evoked by stimulation were recorded with surface elec-
trodes placed in the belly-tendon position with Digitimer Ltd. D360 amplifiers (gain 250, bandpass 3–3000 Hz). 
The first dorsal interosseous was the target muscle whose activity was recorded and sent to a CED Ltd. 1401mkII 
unit 1 (sampling at 10 kHz and storing signals); we also recorded activity from the extensor indicis. Finger move-
ments were monitored using an electrogoniometer (S100) and finger force using a dynamometer (P200), both 
connected to a K800 amplifier (Biometrics Ltd.) and sent to CED1401mkII unit 1 for sampling (10 kHz) and 
storage. In parallel, the force signal was sent to another CED1401mkII (unit 2) run with Sequencer. Sequencer 
(sampling at 100 kHz) ran an algorithm (previously described in detail and  validated8) to trigger TMS at MVC 
peak plateaus and percutaneous nerve stimulation in the resting muscle; the transistor-transistor logic (TTL) 
triggers from CED1401mkII unit 2 to the stimulators were also sent to CED1401mkII unit 1 as TTL markers to 
facilitate offline data processing.
Signal processing and analysed variables. Fatigue was defined as waning of the maximal tapping fre-
quency during task  execution4–8,22,31,46. To analyse fatigue, we tested differences in the variables defined below at 
PRE (i.e., acquired during the first MVC and, for FT frequency and ROM amplitude, during the first 5 s of the 
FT task) and at POST. For POST, we considered the second MVC and the last 5 s of FT for each set (Fig. 1A). 
Customized MATLAB (MathWorks Ltd.) programs were used to extract the following variables, in accordance 
with previous  studies6–8,47:
• Finger-tapping rate The median frequency of all events included in the first 5 s (PRE) and the last 5 s (POST) 
of FT, with tapping cycles obtained from the force  sensor8. For each session and subject, the tapping rates 
at all PRE and POST tested time points were normalised to the maximal FT rate obtained across all testing 
time points and  sets6–8.
• FT ROM amplitude For each tapping cycle, the median value of the goniometric recording during the contact 
phase of tapping was subtracted from the peak value during the movement phase (Fig. 1C). The median 
of all cycles within the same 5 s time window, as above, was defined for PRE and POST. For each session 
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and subject, the ROM amplitude for the PRE and POST time points of all sets was normalised to the ROM 
amplitude recorded during a full range extension movement, which was performed before the FT fatiguing 
 protocol6–8.
• SP duration This was defined as the time from TMS trigger to recovery of EMG activity after the period of 
EMG silence induced by stimulation, as determined  previously6–8. For each subject, the SP duration at the 
different time points was normalised to the mean of all SPs recorded at PRE across conditions for a given 
session, in agreement with previous  studies6–8.
• Half relaxation time and muscle temperature HRT was defined as the time needed for returning from 100% 
(peak force) to 50% in the relaxation phase of the twitch force produced by triple percutaneous nerve stimu-
lation, recorded with the muscle at rest after the MVCs. Within this period, we also extracted the median 
muscle temperature from thermometer recordings.
Apart from the variables cited above that were essential to test our hypotheses, we also analysed the MVC 
force, defined as the median force value in a 50 ms time window just prior to TMS (delivered at MVC  peak8).
Statistical analyses. To test our first hypothesis on the interaction of waning muscle contractility (i.e., 
increase in HRT) and increased M1-GABAb inhibition (SP duration) during fatigue, we performed an analysis 
of variance with repeated measures  (ANOVARM) with the aforementioned variables in the shamTBS session. 
The factors of analyses were TIME (PRE, POST), SET (first, second, third), ISCHAEMIA (with, without), and 
DELAY (T0, T10).
Based on the abovementioned analyses, the second hypothesis was that if the increased M1 inhibition 
observed with fatigue is an adaptation to less functional muscle contractility, increasing excitability with TBS 
would worsen fatigue expressions on FT, and decreasing excitability might provide some benefits, and vice-versa. 
To check this possibility, we used another  ANOVARM, this time adding the kind of stimulation as a factor of 
analysis (STIM) and aftereffect of TBS on each individual’s M1 excitability, tested just prior to FT fatiguing, as a 
covariable. The covariate was included because cTBS can increase excitability rather than produce inhibition in 
many subjects, a paradoxical response also observed for  iTBS41. Thus, two independent ANOVAs were performed 
with factor STIM (shamTBS, cTBS) or STIM (shamTBS, iTBS), each including a covariate.
The covariates were as follows:
• CoVcTBS for ANOVA with (shamTBS, cTBS)
• CoViTBS for ANOVA with (shamTBS, iTBS)
Individual scores for CoVcTBS were calculated as follows: at rest and before the fatigue protocol, we took 
the median of the 20 test MEPs acquired either PRE or POST TBS (Fig. 1A). With these scores from the cTBS 
and shamTBS sessions, we calculated the ratio of POST:PRE for each session. Subsequently, we calculated the 
CoVcTBS as the grand ratio (ratio of the ratios):
If CoVcTBS = 1, this means that the change from PRE to POST was equivalent in the two sessions; 
CoVcTBS < 1 means that cTBS was inhibitory compared to shamTBS, and CoVcTBS > 1 means that cTBS was 
excitatory compared to shamTBS. CoViTBS was calculated in a similar manner.
In another set of analyses, we also considered the changes produced by cTBS and iTBS on LICI to evaluate 
the effects of TBS on the FT profile. We proceeded as above to define  CoVLICIcTBS and  CoVLICIiTBS. However, 
we restricted these analyses to those subjects for whom the PRE-POST TBS changes in the first MEP obtained 
with the paired-TMS pulses were not larger than 30% within sessions. In this way, we could assess how cTBS and 
iTBS changed LICI compared to shamTBS, with similar amplitudes of 1st MEPs. The analyses with  CoVLICIcTBS 
included 10 participants and with  CoVLICIiTBS 9 participants. However, the results were similar to those obtained 
with the whole sample of participants considering CoVcTBS and CoViTBS. Therefore, we omitted the report of 
 CoVLICI analyses in the results section.
In all figures, the graph values represent the mean across subjects along with the SEM. The normality of the 
distributions was checked with the one-sample Kolmogorov–Smirnov test, and the assumption of sphericity was 
tested using the Mauchly test in preparation for ANOVA; if sphericity was violated, the degrees of freedom were 
corrected with Greenhouse–Geisser coefficients. A Bonferroni correction was applied for post hoc comparisons 
within different levels of the factors. A result was considered to be significant when p ≤ 0.0148.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable 
request.
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